K2 SYMPTOMS FACT SHEET NO FURTHER A MYSTERY

These lab-built alternatives weren't developed with recreational use in mind. During the 1990s, John W. Huffman and a workforce of fellow chemists at Clemson College developed a few of the 1st formulation for synthetic cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of cannab